DREAM-HF Phase 3 Trial Results for Mesoblast Cell Therapy in Heart Failure Published in Journal of…
<!-- Name:DistributionId Value:8777798 -->
<!--…
Read More...
Read More...
Browsing Tag
Mesoblast
Mesoblast Submits New Information to FDA IND File in Response to Items in the CRL to the…
NEW YORK, Oct. 02, 2022 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic…
Read More...
Read More...
Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute…
Key Points: Meeting held with the US Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies…
Read More...
Read More...
ASX to rise with Wall Street; IGO, PointsBet, Mesoblast report
Asian stocks look set for a steady open Tuesday as traders assess a technology-led rally in US shares and the latest…
Read More...
Read More...
Mesoblast Presents Respiratory Function Results of COVID-19 ARDS Trial at Pulmonary Disease…
NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic…
Read More...
Read More...